Hensoldt Shares Consolidate Ahead of Key Earnings Test

German defense firm Hensoldt reports record €4.71B orders & strong 2025 profits, but stock trades 30% below peak ahead of crucial Q1 2026 results.

Shares in German defense electronics specialist Hensoldt are trading near €82, a level roughly 30% below their peak last October. This consolidation reflects a market in wait-and-see mode, balancing a record order book against questions about long-term profit trajectory. The stock’s modest 0.9% gain to €81.74 on Wednesday underscores this period of assessment.

The company’s fundamentals present a robust picture. For the full year 2025, Hensoldt reported a surge in order intake to €4.71 billion, a significant jump from €2.90 billion the prior year. This resulted in a book-to-bill ratio of 1.9x, indicating strong future revenue visibility. Adjusted EBITDA reached €452 million, translating to a margin of 18.4%, which exceeded initial management expectations.

Performance was particularly strong in the Optronics segment, where order intake nearly doubled to €1.585 billion, driven by contracts for the Luchs 2 and Leopard 2 platforms. The Sensors unit also saw growth, with revenue rising 8% to approximately €2.06 billion, supported by Eurofighter and air defense radar programs.

This operational strength is flowing through to shareholder returns. The board has proposed a dividend of €0.55 per share for the 2025 financial year, a 10% increase from the previous payout. The virtual Annual General Meeting to approve the distribution is scheduled for 26 May, with payment slated for 27 May. The record date for eligibility is 30 April.

Looking forward, management has set clear targets for 2026, aiming for revenue of around €2.75 billion and an adjusted EBITDA margin between 18.5% and 19%. A key long-term supply agreement underpins this outlook, securing the delivery of 900,000 Gallium Nitride semiconductor components from United Monolithic Semiconductors through 2030, a critical part for modern radar systems.

Analyst opinions on the stock’s path are divided, contributing to its recent trading range. While the consensus price target among 14 covering analysts stands at €91.04, individual views vary widely. JP Morgan recently reiterated a target of €85, yet some forecasts go as high as €114. On the cautious side, analysis firm mwb maintains a "Sell" rating, citing uncertainties over growth beyond 2030.

All eyes are now on the first-quarter 2026 results, due for release on 6 May. This report will be a crucial test, showing how effectively the massive order backlog is converting into revenue and profit, and whether the full-year guidance remains on track. The upcoming AIMS Conference on 14 April and the UDT 2026 exhibition in London from 14-16 April may provide interim commentary, but the May figures are the primary catalyst. With the stock still trading well below its 52-week high of €115.10, the Q1 update could determine if the gap between strong fundamentals and share price performance begins to close.